Brunner's Gland Hyperplasia
Learn about Brunner's Gland Hyperplasia, also known as Brunner's gland adenoma or duodenal gland hyperplasia. This resource provides information on diagnosis, clinical documentation, and medical coding for Brunner's Gland Hyperplasia. Find details relevant to healthcare professionals, including ICD-10 codes and best practices for documenting this duodenal condition in patient records. Understand the key differences between Brunner's Gland Hyperplasia and other duodenal pathologies for accurate clinical documentation and medical coding.
Overgrowth of Brunner's glands in the duodenum (first part of small intestine).
Often asymptomatic. Can cause upper GI bleeding, abdominal pain, nausea, and rarely, obstruction.
Detected incidentally during endoscopy or imaging for other GI issues.
ICD-10 Code Families
Complete code families applicable to K31.7
When to use each related code
| Description | When to use |
|---|---|
| Excess Brunner's gland tissue in duodenum. | Use for diffuse or multiple Brunner's gland enlargements. Consider adenoma for solitary lesions. |
| Benign Brunner's gland tumor in duodenum. | Use for a single, localized Brunner's gland enlargement. May cause bleeding or obstruction. |
| Duodenal inflammation near Brunner's glands. | Use when inflammation affects the duodenum near Brunner's glands. Often associated with H. pylori. |
Best-practice checklist
- ✓Document duodenal location and extent.
- ✓Describe endoscopic findings (size, number, appearance).
- ✓Histopathology report confirming Brunner's gland hyperplasia.
- ✓Rule out other duodenal pathologies.
- ✓ICD-10-CM code K31.8 for documentation and billing.
Common pitfalls to avoid
Coding Brunner's gland hyperplasia requires specifying duodenum or other location. Unspecified site leads to coding errors and claim rejections.
Distinguishing Brunner's gland hyperplasia from atypical hyperplasia or neoplasia is crucial for accurate coding and treatment planning. Misdiagnosis impacts patient care and reimbursement.
Coding based on clinical findings, not just pathology reports, ensures accurate code assignment for Brunner's gland hyperplasia. Insufficient documentation can lead to audits and denials.
Best-practice tips
- 01Document duodenal location, size, and number of Brunner's gland lesions for ICD-10-CM K31.8
- 02Code K31.8 for Brunner's gland hyperplasia, adenoma, or duodenal gland hyperplasia
- 03Correlate endoscopic findings with histology for Brunner's gland hyperplasia diagnosis
- 04Distinguish Brunner's gland hyperplasia from other duodenal lesions in documentation
- 05For symptomatic cases, link Brunner's gland hyperplasia to symptoms in clinical notes
Step-by-step checklist
- 1
Confirm duodenal location of lesion via endoscopy/imaging.
- 2
Histopathology report confirms Brunner's gland hyperplasia.
- 3
Exclude other duodenal pathologies (e.g., adenoma, carcinoma).
- 4
Assess for symptoms like GI bleeding, obstruction, or abdominal pain.
Ready-to-paste narrative
Patient presents with symptoms suggestive of Brunner's Gland Hyperplasia, including abdominal pain, dyspepsia, and nausea. Differential diagnosis includes peptic ulcer disease, gastritis, and duodenal adenoma. Physical examination was unremarkable. Upper endoscopy revealed prominent submucosal nodules in the duodenum, consistent with Brunner's gland hyperplasia or Brunner's gland adenoma. Biopsies were taken and sent for histopathological analysis to confirm the diagnosis and rule out malignancy. The patient's symptoms, endoscopic findings, and potential for complications like gastrointestinal bleeding or obstruction warrant further investigation. Preliminary diagnosis of duodenal gland hyperplasia is considered. Treatment options, including medical management with proton pump inhibitors or H2 blockers for symptom control and surgical resection for larger or symptomatic lesions, will be discussed upon receiving pathology results. ICD-10 code D13.7 is tentatively assigned, pending histopathologic confirmation. CPT codes for the endoscopic procedure and biopsy, such as 43239 and 43235 respectively, are also documented. This assessment will be updated following the review of the biopsy findings and correlation with the patient's clinical presentation.
Common questions and answers
What are the key endoscopic and histologic features that differentiate Brunner's Gland Hyperplasia from other duodenal lesions like Brunner's gland adenoma or a duodenal carcinoid?+
Differentiating Brunner's Gland Hyperplasia (BGH) from other duodenal lesions requires careful endoscopic and histologic evaluation. Endoscopically, BGH typically presents as multiple, small, sessile or pedunculated nodules in the duodenal bulb, often appearing as a cobblestone or grape-like cluster. Brunner's gland adenomas are usually solitary and larger. Duodenal carcinoids can also appear as nodules but may exhibit central umbilication or ulceration. Histologically, BGH demonstrates diffuse proliferation of Brunner's glands without architectural distortion, while adenomas show localized, encapsulated glandular growth with some architectural distortion. Carcinoids exhibit characteristic neuroendocrine features with uniform cells arranged in nests or trabeculae. Immunohistochemical stains can be helpful in challenging cases. Explore how these features aid in accurate diagnosis and guide appropriate management strategies.
When is endoscopic resection indicated for Brunner's Gland Hyperplasia, and what are the preferred techniques (e.g., snare polypectomy, endoscopic mucosal resection, etc.) considering potential complications like bleeding or perforation?+
While Brunner's Gland Hyperplasia (BGH) is often asymptomatic and doesn't require intervention, endoscopic resection is indicated when symptoms like duodenal obstruction, bleeding, or persistent abdominal pain arise. Additionally, large or suspicious lesions warrant resection to exclude malignancy or Brunner's gland adenoma. Preferred endoscopic techniques include snare polypectomy for smaller, pedunculated lesions and endoscopic mucosal resection (EMR) for larger, sessile lesions. Endoscopic submucosal dissection (ESD) may be considered for complex cases. Potential complications like bleeding and perforation are rare but possible. Careful consideration of lesion size, location, and morphology is crucial in selecting the appropriate technique and minimizing risks. Consider implementing a standardized endoscopic approach to enhance patient safety and optimize outcomes. Learn more about the latest advancements in endoscopic resection techniques for duodenal lesions.
How can I effectively manage a patient with symptomatic Brunner's Gland Hyperplasia who is not a suitable candidate for endoscopic intervention due to comorbidities or other factors?+
Managing symptomatic Brunner's Gland Hyperplasia (BGH) in patients unsuitable for endoscopic intervention requires a tailored approach focusing on symptom control. For patients experiencing abdominal pain or discomfort, proton pump inhibitors (PPIs) can reduce acid secretion and alleviate symptoms. H2 blockers can also be considered. For patients with bleeding, medical management with endoscopic hemostasis or angiography may be necessary. If obstruction is present, prokinetics can be used to improve duodenal motility. Lifestyle modifications, such as dietary adjustments and stress management, may also provide benefit. Close monitoring is essential, and regular follow-up endoscopy should be considered to assess for any changes in the lesion. Explore how a multidisciplinary approach involving gastroenterologists, surgeons, and other specialists can help optimize the management of complex BGH cases.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.